39 results
Novel Supreme DES with early synchronized antiproliferative drug delivery to inhibit smooth muscle cell proliferation after DES implantation in coronary artery disease: results of the PIONEER III randomized clinical trial
06 May 2021
The PIONEER III trial aims to assess the effectiveness and safety of the biodegradable-polymer sirolimus-eluting Supreme stent compared to durable-polymer everolimus-eluting stent (Xience or Promus), completely releasing the drug by 120 days.
Reviewer
Impact of post-stenting fractional flow reserve on long-term clinical outcomes - The FFR-SEARCH Study
29 Apr 2021
The objective of this analysis was to prospectively investigate the clinical impact of post-PCI FFR values on long-term clinical outcomes.
Reviewer
Long-term safety of drug-coated devices for peripheral revascularisation
01 Feb 2021
In this large cohort, there was no evidence of increased long-term mortality following treatment with drug-coated devices. Read the review to find out more.
Reviewer
Aspirin-free prasugrel monotherapy following coronary artery stenting in patients with stable CAD
27 Oct 2020
The ASET pilot study: a multicenter, single-arm, first-in-human and proof-of-concept trial which included a total of 212 low-risk patients with stable coronary artery disease
Reviewer
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome
06 Oct 2020
Reviewer
Long‐term safety of paclitaxel drug‐coated balloon‐only angioplasty for de novo coronary artery disease: the SPARTAN DCB study
16 Sep 2020
This study adds to the growing body of evidence demonstrating that DCB is a safe option for the treatment of de novo coronary lesions with NO signal towards increase in mortality up to 5-year follow-up.
Reviewer
Reviewer
Randomised comparison of the polymer-free biolimus-coated BioFreedom stent with the ultrathin strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with PCI: the SORT OUT IX Trial
03 Jul 2020
While investigations testing differences in efficacy and safety between drug-eluting stents according to the characteristics of the coating – durable, bioresorbable, or polymer-free – have shown mixed results, several studies have highlighted the benefit of implanting a device with thinner strut.
Reviewer
Impact of kissing balloon in patients treated with ultrathin stents for left main lesions and bifurcations: an analysis from the RAIN-CARDIOGROUP VII study
26 Mar 2020
The objective of this analysis was to investigate the potential benefits of FKI in bifurcations treated with new generation ultrathin stents using a 1- or 2-stent technique.
Reviewer
Reviewer
Percutaneous treatment and outcomes of small coronary vessels: A SCAAR report
04 Mar 2020
Using the SCAAR database, this observational, nationwide, multicentre cohort study compared outcomes of all consecutive patients undergoing PCI for de-novo stenosis in small coronary vessels (device diameter ≤2.5mm) treated with drug-coated balloons or newer generation drug-eluting stents.
Reviewer
Reviewer
Polymer-based or polymer-free stents in patients at high bleeding risk: ONYX ONE
24 Feb 2020
The objective of the ONYX ONE study was to compare the safety and effectiveness of the polymer-based or polymer-free stents in patients at high bleeding risk receiving 1 month of DAPT.
Reviewer
